Home › Islet Cell Adenoma › Tennessee › Nashville
Islet Cell Adenoma clinical trials in Nashville, TN
3 studies for Islet Cell Adenoma are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- Henry-Joyce Cancer Clinic, Nashville
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
RecruitingPhase 2
- Vanderbilt University Medical Center ( Site 0107), Nashville
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RecruitingPhase 1
- Research Facility, Nashville
Islet Cell Adenoma trials in other cities
- Rochester, MN5 studies
- Los Angeles, CA5 studies
- Washington, DC4 studies
- St. Louis, MO4 studies
- Phoenix, AZ4 studies
- Portland, OR4 studies
- Chicago, IL4 studies
- Philadelphia, PA3 studies
- Jacksonville, FL3 studies
- Salt Lake City, UT3 studies
- Lexington, KY3 studies
- Boston, MA3 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.